Single-Cell Transcriptomics Uncovers Zonation of Function in the Mesenchyme during Liver Fibrosis

Ross Dobie(Centre for Inflammation Research), John R. Wilson‐Kanamori(University of Edinburgh), Beth E. P. Henderson(University of Edinburgh), James R. Smith(University of Edinburgh), Kylie P. Matchett(University of Edinburgh), Jordan R. Portman(Centre for Inflammation Research), Karolina Wallenborg(Science for Life Laboratory), Simone Picelli(Karolinska Institutet), Anna Zagórska(Gilead Sciences (United States)), Swetha Pendem(Gilead Sciences (United States)), Thomas E. Hudson(Gilead Sciences (United States)), Minnie M. Wu(Gilead Sciences (United States)), Grant R. Budas(Gilead Sciences (United States)), David G. Breckenridge(Gilead Sciences (United States)), Ewen M. Harrison(Edinburgh Royal Infirmary), Damian J. Mole(University of Edinburgh), Stephen J. Wigmore(University of Edinburgh), Prakash Ramachandran(The Queen's Medical Research Institute), Chris P. Ponting(MRC Institute of Genetics and Molecular Medicine), Sarah A. Teichmann(European Bioinformatics Institute), John C. Marioni(Wellcome Sanger Institute), Neil C. Henderson(University of Edinburgh)
Cell Reports
November 1, 2019
Cited by 422Open Access
Full Text

Abstract

Iterative liver injury results in progressive fibrosis disrupting hepatic architecture, regeneration potential, and liver function. Hepatic stellate cells (HSCs) are a major source of pathological matrix during fibrosis and are thought to be a functionally homogeneous population. Here, we use single-cell RNA sequencing to deconvolve the hepatic mesenchyme in healthy and fibrotic mouse liver, revealing spatial zonation of HSCs across the hepatic lobule. Furthermore, we show that HSCs partition into topographically diametric lobule regions, designated portal vein-associated HSCs (PaHSCs) and central vein-associated HSCs (CaHSCs). Importantly we uncover functional zonation, identifying CaHSCs as the dominant pathogenic collagen-producing cells in a mouse model of centrilobular fibrosis. Finally, we identify LPAR1 as a therapeutic target on collagen-producing CaHSCs, demonstrating that blockade of LPAR1 inhibits liver fibrosis in a rodent NASH model. Taken together, our work illustrates the power of single-cell transcriptomics to resolve the key collagen-producing cells driving liver fibrosis with high precision.


Related Papers

No related papers found

Powered by citation graph analysis